Hemispherx Biopharma Inc (HEB):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Hemispherx Biopharma Inc (HEB) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7341
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Hemispherx Biopharma Inc (Hemispherx) is a biopharmaceutical company, which develops, manufactures and commercializes drug therapies for the treatments of viral and immune based chronic disorders. It offers products for the treatment of various diseases such as hepatitis B, hepatitis C, chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME), kidney cancer and metastatic malignant melanoma; multiple sclerosis, hepatitis C, HIV, west Nile virus, and SARS; and Alferon LDO (Low Dose Oral), an oral form of Alferon N Injection for influenza viruses. The company operates production facility in New Brunswick, New Jersey. Hemispherx is headquartered in Orlando, Florida, the US.

Hemispherx Biopharma Inc (HEB) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Hemispherx Biopharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Hemispherx Biopharma Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Hemispherx Biopharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Hemispherx Biopharma Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Hemispherx Biopharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Hemispherx Biopharma Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Hemispherx Biopharma Plans to Raise up to USD75 Million in Public Offering of Securities 10
Hemispherx Biopharma to Raise USD2.6 Million in Private Placement of Shares 11
Hemispherx Biopharma to Raise USD0.5 Million in Private Placement of Shares 12
Hemispherx Biopharma Plans to Raise USD1.6 Million in Public Offering of Shares 13
Hemispherx Biopharma Inc – Key Competitors 14
Hemispherx Biopharma Inc – Key Employees 15
Hemispherx Biopharma Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Financial Announcements 17
Aug 15, 2018: Hemispherx announces six months ended June 30, 2018 financial results 17
May 16, 2018: Hemispherx Biopharma Reports First Quarter 2018 Financial Results and Provides Business Update 18
Apr 02, 2018: Hemispherx Biopharma Announced Financial Results for the Year Ended December 31, 2017 19
Nov 15, 2017: Hemispherx Biopharma Announces Corporate Progress and Financial Results for the Nine Months Ended September 30, 2017 20
Product News 21
May 14, 2018: Hemispherx to Present at the 4th Annual Immuno-Oncology: BD&L and Investment Forum 21
Aug 04, 2017: Hemispherx Encouraged by Cytokine Biomarker Discovery Which May Lead to a Diagnostic for Chronic Fatigue Syndrome 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Hemispherx Biopharma Inc, Medical Equipment, Key Facts, 2017 2
Hemispherx Biopharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Hemispherx Biopharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Hemispherx Biopharma Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Hemispherx Biopharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Hemispherx Biopharma Inc, Deals By Market, 2012 to YTD 2018 8
Hemispherx Biopharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Hemispherx Biopharma Plans to Raise up to USD75 Million in Public Offering of Securities 10
Hemispherx Biopharma to Raise USD2.6 Million in Private Placement of Shares 11
Hemispherx Biopharma to Raise USD0.5 Million in Private Placement of Shares 12
Hemispherx Biopharma Plans to Raise USD1.6 Million in Public Offering of Shares 13
Hemispherx Biopharma Inc, Key Competitors 14
Hemispherx Biopharma Inc, Key Employees 15
Hemispherx Biopharma Inc, Other Locations 16
Hemispherx Biopharma Inc, Subsidiaries 16

List of Figures
Hemispherx Biopharma Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Hemispherx Biopharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Hemispherx Biopharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Hemispherx Biopharma Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Hemispherx Biopharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Hemispherx Biopharma Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Hemispherx Biopharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Hemispherx Biopharma Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Hemispherx Biopharma Inc (HEB):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • VertiFlex Inc:医療機器:M&Aディール及び事業提携情報
    Summary VertiFlex Inc (Vertiflex) is a medical device company that offers invasive treatments for lumbar stenosis. The company offers products such as interspinous spacer and direct decompression systems. Its interspinous spacer system is a motion-preserving, indirect decompression spinal implant sy …
  • Acceleron Pharma Inc (XLRN):企業の財務・戦略的SWOT分析
    Acceleron Pharma Inc (XLRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Toagosei Co Ltd (4045):企業の財務・戦略的SWOT分析
    Toagosei Co Ltd (4045) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Alert Logic Inc:企業の戦略的SWOT分析
    Alert Logic Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Sime Darby Bhd (SIME):電力:M&Aディール及び事業提携情報
    Summary Sime Darby Bhd (Sime Darby) is a trading and logistics company. It provides diversified products and services through its subsidiaries, affiliates, and joint ventures. The company cultivates oil palm, rubber and sugarcane; rears cattle; and produces oil and fats. It also imports, assembles, …
  • HORNBACH-Baumarkt-AG (HBM):企業の財務・戦略的SWOT分析
    HORNBACH-Baumarkt-AG (HBM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Grill Concepts, Inc.:企業の戦略・SWOT・財務情報
    Grill Concepts, Inc. - Strategy, SWOT and Corporate Finance Report Summary Grill Concepts, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • United Services Automobile Association:企業のM&A・事業提携・投資動向
    United Services Automobile Association - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's United Services Automobile Association Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed repo …
  • ZincX Resources Corp:企業の戦略・SWOT・財務分析
    ZincX Resources Corp - Strategy, SWOT and Corporate Finance Report Summary ZincX Resources Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Theradex Systems Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Theradex Systems Inc (Theradex) is a research organization that provides clinical trials monitoring services. The organization develops medical devices, pharmaceutical compounds and diagnostic tests in the areas of oncology and life-threatening diseases. It provides services such as clinical …
  • M3 Biotechnology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary M3 Biotechnology Inc (M3 Biotech) is a clinical stage biotech company that focuses on regenerative medicine. The company is developing clinical programs for the treatment of Alzheimer, MS, Parkinson and Alzheimerdisease (oral) among others. It utilizes discovery platform and develops small m …
  • Achaogen Inc (AKAO)-製薬・医療分野:企業M&A・提携分析
    Summary Achaogen Inc (Achaogen) is a biopharmaceutical company that discovers, develops and commercializes novel anti bacterials for the treatment of multi-drug resistant and gram-negative infections. The company is developing plazomicin for the treatment of serious bacterial infections due to MDR E …
  • Hikma Pharmaceuticals Plc (HIK):企業の財務・戦略的SWOT分析
    Hikma Pharmaceuticals Plc (HIK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Shenzhen Kaifa Technology Co Ltd (000021):企業の財務・戦略的SWOT分析
    Shenzhen Kaifa Technology Co Ltd (000021) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Hanwha Life Insurance Co Ltd:戦略・SWOT・企業財務分析
    Hanwha Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Hanwha Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • SunPower Corporation (SPWR):電力:M&Aディール及び事業提携情報
    Summary SunPower Corporation (SunPower), a subsidiary of Total Solar International SAS, is a provider of solar technology and energy services. The company has a presence in solar value chain from cell and panel manufacturing, project development, project finance through engineering, procurement, and …
  • Guerbet SA (GBT):企業の財務・戦略的SWOT分析
    Guerbet SA (GBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Mercy:企業の戦略的SWOT分析
    Mercy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This u …
  • MannKind Corp (MNKD)-医療機器分野:企業M&A・提携分析
    Summary MannKind Corp (MannKind) is a biopharmaceutical company that discovers, develops and commercializes therapeutic products to treat diseases such as diabetes. The company’s lead product, Afrezza is a rapid-acting, inhaled insulin used to control high blood sugar in adults with type 1 and type …
  • Regeneron Pharmaceuticals Inc (REGN):企業の財務・戦略的SWOT分析
    Regeneron Pharmaceuticals Inc (REGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆